Obstetrics, gynecology, andrology, sexual and reproductive health

Osteoporosis

Glucocorticoid-induced osteoporosis

• Belgium
  • Belgian Bone Club
    • Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club [2022]
• Brazil
  • Revista Brasileira de Reumatologia
    • Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis [2012]
• East Asia
  • Current Pharmaceutical Design
    • Treatment of Glucocorticoid-Induced Osteoporosis with Bisphosphonates Alone, Vitamin D Alone or a Combination Treatment in Eastern Asians: A Meta-Analysis [2019]
• International
  • Journal of Bone Metabolism
    • Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines [2020]
  • PLoS ONE
    • Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials [2020]
  • Rheumatology Advances in Practice
    • The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis [2020]
• Japan
  • Acta Medica Okayama
    • Guideline-based Treatment of Glucocorticoid-induced Osteoporosis in Patients with Rheumatoid Arthritis: A Retrospective Study with the AORA Registry [2021]
  • Journal of Osteoporosis
    • Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases [2021]
• Netherlands
  • Osteoporosis International
    • Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial [2013]
• Norway
  • Archives of Osteoporosis
    • Initiation of anti-osteoporotic drugs in high-risk female patients starting glucocorticoid treatment: a population study in Norway [2020]
• Republic of Korea
  • Endocrinology and Metabolism
    • Update on Glucocorticoid Induced Osteoporosis [2021]
  • Journal of Bone Metabolism
    • Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis [2018]
  • Korean Journal of Internal Medicine
    • Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis? [2014]
• Taiwan
  • Medicine
    • Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid [2017]
  • Tzu-Chi Medical Journal
    • The molecular etiology and treatment of glucocorticoid-induced osteoporosis [2021]
• United Kingdom
  • NPJ Primary Care Respiratory Medicine
    • A retrospective database study of oral corticosteroid and bisphosphonate prescribing patterns in England [2020]
• United States
  • American College of Rheumatology
    • 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis [2017]
  • Arthritis Care & Research
    • United States Adults Meeting 2010 American College of Rheumatology Criteria for Treatment and Prevention of Glucocorticoid-Induced Osteoporosis [2014]
  • Cleveland Clinic Journal of Medicine
    • Glucocorticoid-induced osteoporosis: Insights for the clinician [2020]
• {Related topics}
  • Guidelines
    • Osteoporosis

Male osteoporosis

• Australia
  • Medical Journal of Australia
    • Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy [2011]
• Brazil
  • Revista Brasileira de Reumatologia
    • Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men [2017]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Denosumab (Prolia): Treatment to Increase Bone Mass in Men with Osteoporosis at High Risk for Fracture; or Who Have Failed or are Intolerant to Other Available Osteoporosis Therapy [2015]
  • Journal of Bone and Mineral Research
    • The burden of illness of osteoporosis in Canadian men [2012]
• Europe
  • European Academy of Andrology
    • EAA clinical guideline on management of bone health in the andrological outpatient clinic [2018]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Treatment of osteoporosis in men [2012]
• High-income countries
  • PharmacoEconomics
    • Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review [2023]
• International
  • Clinical Epidemiology
    • The clinical epidemiology of male osteoporosis: a review of the recent literature [2015]
  • International Journal of Molecular Sciences
    • Osteoporosis in Men: A Review of an Underestimated Bone Condition [2021]
  • International Osteoporosis Foundation
    • The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the International Osteoporosis Foundation [2017]
    • Towards a diagnostic and therapeutic consensus in male osteoporosis [2011]
  • Prostate Cancer and Prostatic Diseases
    • Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update [2017]
• Malaysia
  • International Journal of Environmental Research and Public Health
    • Lessons from the Bone Chapter of the Malaysian Aging Men Study [2016]
• Republic of Korea
  • Journal of Osteoporosis
    • A New Predictive Index for Osteoporosis in Men under 70 Years of Age: An Index to Identify Male Candidates for Osteoporosis Screening by Bone Mineral Density [2014]
  • Korean Journal of Family Medicine
    • Evaluation of the Predictive Index for Osteoporosis as a Clinical Tool to Identify the Risk of Osteoporosis in Korean Men by Using the Korea National Health and Nutrition Examination Survey Data [2016]
  • Scientific Reports
    • Androgen-deprivation therapy and the risk of newly developed fractures in patients with prostate cancer: a nationwide cohort study in Korea [2021]
  • Yonsei Medical Journal
    • Development and Validation of Osteoporosis Risk-Assessment Model for Korean Men [2015]
• Spain
  • World Journal of Men's Health
    • Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy [2022]
• Sweden
  • Bone
    • Low-level cadmium exposure is associated with decreased cortical thickness, cortical area and trabecular bone volume fraction in elderly men: The MrOS Sweden study [2021]
• United Kingdom
  • Journal of Bone Oncology
    • Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group [2020]
  • NHS England
    • Interim clinical commissioning policy statement: Teriparatide for osteoporosis in men (adults) [2021]
• United States
  • American College of Physicians
    • Screening for Osteoporosis in Men: A Systematic Review for an American College of Physicians Guideline [2008]
    • Screening for Osteoporosis in Men: A Clinical Practice Guideline from the American College of Physicians [2008]
  • Annals of Family Medicine
    • Comparison of the Male Osteoporosis Risk Estimation Score (MORES) With FRAX in Identifying Men at Risk for Osteoporosis [2016]
  • BoneKEy Reports
    • Sensitivity of osteoporosis screening guidelines for eventual hip fracture in older male veterans [2014]
  • Clinical Interventions in Aging
    • Osteoporosis in men: epidemiology and treatment with denosumab [2014]
  • Endocrine Practice
    • Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey [2020]
    • Practice Patterns in the Treatment of Male Osteoporosis [2019]
  • Endocrine Society
    • Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline [2012]
  • Journal of Osteoporosis
    • Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective [2015]
  • Permanente Journal
    • Are Men at High Risk for Osteoporosis Underscreened? A Quality Improvement Project [2016]
  • U.S. Department of Veterans Affairs
    • Screening for Male Osteoporosis: A Systematic Review [2022]
• {Related topics}
  • Guidelines
    • Osteoporosis

Osteoporosis

• Africa
  • Archives of Osteoporosis
    • Consensus evidence-based clinical practice guidelines for the diagnosis and treat-to-target management of osteoporosis in Africa: an initiative by the African Society of Bone Health and Metabolic Bone Diseases [2021]
• Arab countries
  • Mediterranean Journal of Rheumatology
    • Pan Arab Osteoporosis Society Guidelines for Osteoporosis Management [2017]
• Asia-Pacific
  • Asia Pacific Consortium on Osteoporosis
    • Harmonization of Osteoporosis Guidelines: Paving the Way for Disrupting the Status Quo in Osteoporosis Management in the Asia Pacific [2022]
    • Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region [2021]
    • IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific [2020]
• Australia
  • Archives of Osteoporosis
    • Trends in osteoporosis diagnosis and management in Australia [2022]
  • Australian Family Physician
    • Osteosarcopenia: A new geriatric syndrome [2017]
  • Australian Institute of Health and Welfare
    • Osteoporosis [2020]
  • Royal Australian College of General Practitioners
    • Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age [2017]
• Belgium
  • Belgian Bone Club
    • The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women [2020]
    • How to manage osteoporosis before the age of 50 [2020]
    • Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club [2017]
• Brazil
  • Revista Brasileira de Reumatologia
    • Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis [2017]
• Canada
  • BCGuidelines
    • Osteoporosis: Diagnosis, treatment and fracture prevention [2012]
  • Canadian Family Physician
    • Osteoporosis management in residential care [2017]
    • Osteoporosis guideline implementation in family medicine using electronic medical records [2016]
  • Journal of the American Association of Nurse Practitioners
    • Screening, assessment, and treatment of osteoporosis for the nurse practitioner: Key questions and answers for clinical practice—A Canadian perspective [2014]
  • Osteoporosis Canada
    • 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada [2010]
  • Osteoporosis International
    • A scorecard for osteoporosis in Canada and seven Canadian provinces [2021]
  • Public Health Agency of Canada
    • Osteoporosis and related fractures in Canada: Report from the Canadian Chronic Disease Surveillance System 2020 [2020]
    • Screening, prevention and management of osteoporosis among Canadian adults [2018]
  • Society of Obstetricians and Gynaecologists of Canada
    • Menopause and Osteoporosis [2022]
• Canada, United States
  • Journal of Bone and Mineral Metabolism
    • A Comparison of U.S. and Canadian Osteoporosis Screening and Treatment Strategies in Postmenopausal Women [2019]
  • North American Menopause Society
    • Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society [2021]
• Europe
  • Archives of Osteoporosis
    • SCOPE: a scorecard for osteoporosis in Europe [2013]
  • European Alliance of Associations for Rheumatology
    • 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older [2021]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • European guidance for the diagnosis and management of osteoporosis in postmenopausal women [2019]
  • European Society of Human Reproduction and Embryology
    • Bone fractures after menopause [2010]
  • International Osteoporosis Foundation
    • SCOPE 2021: a new scorecard for osteoporosis in Europe [2021]
    • Fragility fractures in Europe: burden, management and opportunities [2020]
  • WHO European Region
    • What evidence is there for the prevention and screening of osteoporosis? [2006]
• France
  • HAL
    • 2018 Update of French Recommendations on the Management of Postmenopausal Osteoporosis [2018]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "osteoporosis" [2016]
  • Journal of Orthopaedic Surgery and Research
    • Investigation and management of osteoporosis in aged trauma patients: a treatment algorithm adapted to the German guidelines for osteoporosis [2017]
• Greece
  • Journal of Musculoskeletal and Neuronal Interactions
    • 2011 guidelines for the diagnosis and treatment of osteoporosis in Greece [2012]
• Hong Kong
  • Osteoporosis Society of Hong Kong
    • The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong [2013]
• Iceland
  • Computational and Mathematical Methods in Medicine
    • A Clinical Decision Support System for the Diagnosis, Fracture Risks and Treatment of Osteoporosis [2015]
• India
  • International Journal of Women's Health
    • Epidemiology and treatment of osteoporosis in women: an Indian perspective [2015]
  • Journal of Clinical and Diagnostic Research
    • Current Clinical Practice Scenario of Osteoporosis Management in India [2015]
  • Journal of Mid-Life Health
    • Clinical Practice Guidelines on Postmenopausal Osteoporosis: An Executive Summary and Recommendations – Update 2019–2020 [2020]
• International
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation [2019]
  • International Osteoporosis Foundation
    • Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement [2022]
    • A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network [2020]
    • Health professionals
• Iran
  • BMC Musculoskeletal Disorders
    • Direct costs of common osteoporotic fractures (Hip, Vertebral and Forearm) in Iran [2021]
• Ireland, United Kingdom
  • Calcified Tissue International
    • Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance [2021]
• Israel
  • Israel Medical Association Journal
    • Osteoporosis: A Future Public Health Problem for Israel? Medical and Legal Obligations [2017]
  • PLoS ONE
    • Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel [2016]
• Italy
  • Aging Clinical and Experimental Research
    • Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management [2020]
  • Clinical Cases in Mineral and Bone Metabolism
    • Guidance for the diagnosis, prevention and therapy of osteoporosis in Italy [2012]
  • Internal and Emergency Medicine
    • Guidelines for the management of osteoporosis and fragility fractures [2019]
  • Reumatismo
    • Guidelines for the diagnosis, prevention and management of osteoporosis [2016]
• Japan
  • Endocrine Journal
    • Multidisciplinary approach to management of osteoporosis with osteoporosis liaison service (OLS) [2023]
• Kuwait
  • Kuwait Osteoporosis Society
    • Kuwait Osteoporosis Guidelines 2018 [2018]
• Latin America
  • Archives of Osteoporosis
    • Joint position statement on management of patient with osteoporosis during COVID-19 contingency from the AMMOM, CONAMEGER, FELAEN, FEMECOG, FEMECOT, and ICAAFYD [2021]
• Malaysia
  • Ministry of Health Malaysia
    • Clinical Guidance on Management of Osteoporosis [2015]
• Middle East, North Africa
  • Journal of Musculoskeletal and Neuronal Interactions
    • Middle East and North Africa consensus on osteoporosis [2007]
• Netherlands
  • Archives of Osteoporosis
    • Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey [2021]
• New Zealand
  • Osteoporosis New Zealand
    • Guidance on the Diagnosis and Management of Osteoporosis in New Zealand [2017]
• Poland
  • Endokrynologia Polska
    • Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022 [2023]
    • Guidelines for the diagnosis and management of osteoporosis in Poland : Update 2017 [2017]
  • Polish Archives of Internal Medicine
    • Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update [2014]
• Portugal
  • Acta Reumatológica Portuguesa
    • Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update [2018]
    • Multidisciplinary Portuguese recommendations on DXA request and indication to treat in the prevention of fragility fractures [2016]
• Republic of Korea
  • Journal of Bone Metabolism
    • Review of Epidemiology, Diagnosis, and Treatment of Osteosarcopenia in Korea [2018]
    • Comparison in Adherence to Osteoporosis Guidelines according to Bone Health Status in Korean Adult [2016]
• Saudi Arabia
  • Annals of Saudi Medicine
    • 2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society [2015]
    • Updated Recommendations for the Diagnosis and Management of Osteoporosis: A Local Perspective [2011]
  • Ministry of Health Saudi Arabia
    • National Plan for Osteoporosis Prevention and Management in the Kingdom of Saudi Arabia [2018]
  • Saudi Medical Journal
    • Osteoporosis in Saudi Arabia. Are we doing enough? [2015]
• Singapore
  • Agency for Care Effectiveness
    • Osteoporosis — identification and management in primary care [2018]
  • Annals Academy of Medicine Singapore
    • Tackling osteoporosis and fragility fractures in Singapore [2021]
• Spain
  • Pediatric Rheumatology Online Journal
    • Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children [2020]
  • Reumatología Clínica
    • Recommendations by the Spanish Society of Rheumatology on Osteoporosis [2019]
  • Revista Clínica Española (English Edition)
    • Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM) [2022]
• Taiwan
  • Health Promotion Administration
    • Taiwan Osteoporosis Practice Guidelines [2012]
  • Osteoporosis and Sarcopenia
    • The development of Taiwan Fracture Liaison Service network [2018]
• Thailand
  • Osteoporosis and Sarcopenia
    • Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis [2016]
• Turkey
  • Archives of Osteoporosis
    • Updated approach for the management of osteoporosis in Turkey: a consensus report [2020]
• United Kingdom
  • Healthcare Improvement Scotland
    • Management of osteoporosis and the prevention of fragility fractures [2021]
  • National Institute for Health and Care Excellence
    • Osteoporosis (Quality standard) [2017]
    • Osteoporosis
  • National Osteoporosis Guideline Group
    • Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 [2013]
  • Osteoporosis International
    • Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement [2021]
  • Public Health England
    • Falls and fractures: consensus statement and resources pack
• United States
  • American Association of Clinical Endocrinologists
    • American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update Executive Summary [2020]
  • American Family Physician
    • Diagnosis and Management of Osteoporosis [2015]
  • American Society for Bone and Mineral Research
    • Osteoporosis Management in the Era of COVID-19 [2020]
  • Annals of Pharmacotherapy
    • Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population [2021]
  • Clinical Medicine & Research
    • Management of Osteoporosis and Spinal Fractures: Contemporary Guidelines and Evolving Paradigms [2022]
  • Journal of Clinical Densitometry
    • Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases [2022]
    • Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases [2017]
  • OTA International
    • Osteoporosis management in the United States [2022]
• WHO
  • World Health Organization
    • Prevention and management of osteoporosis: report of a WHO scientific group [2003]
• {Related topics}
  • Guidelines
    • Osteoporosis: screening, diagnosis
    • Osteoporosis: risk factors
    • Osteoporosis: prevention, treatment
    • Osteoporosis: kidney diseases
    • Osteoporosis: epidemiology
    • Osteoporosis: digestive system diseases
    • Menopause, hormone replacement therapy
    • Male osteoporosis
    • Glucocorticoid-induced osteoporosis

Osteoporosis: bisphosphonates

• Belgium
  • Belgian Bone Club
    • Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club [2009]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Duration of Bisphosphonate Treatment for Patients with Osteoporosis: A Review of Clinical Effectiveness and Guidelines [2019]
  • Canadian Family Physician
    • Bisphosphonates: forever or 5 years and stop? [2015]
    • Bisphosphonates for treatment of osteoporosis. Expected benefits, potential harms, and drug holidays [2014]
• China
  • Osteoporosis International
    • Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data [2020]
• Deveped countries
  • BMJ Open
    • Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis [2020]
• Europe
  • European Calcified Tissue Society
    • Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society [2020]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report [2010]
• France
  • International Journal of Environmental Research and Public Health
    • Bisphosphonate Use and Hospitalization for Hip Fractures in Women: An Observational Population-Based Study in France [2021]
  • Scientific Reports
    • Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database [2020]
• International
  • BMJ Open
    • Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review [2019]
  • Frontiers in Endocrinology
    • The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis [2021]
  • International Osteoporosis Foundation
    • International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates [2017]
  • Sao Paulo Medical Journal
    • Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis [2023]
• Japan
  • Journal of Bone and Mineral Metabolism
    • Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw [2017]
• New Zealand
  • Starship
    • Endocrinology - intravenous bisphosphonate therapy [2021]
• Norway
  • Norwegian Institute of Public Health
    • Efficacy and Cost-Effectiveness of Alendronate for the Prevention of Fractures in Postmenopausal Women in Norway [2011]
  • Osteoporosis International
    • Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway [2021]
• Republic of Korea
  • Journal of Bone Metabolism
    • Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea [2015]
    • Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons [2015]
  • Journal of Korean Medical Science
    • Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort [2020]
• Singapore
  • Osteoporosis International
    • Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women [2021]
• Taiwan
  • Journal of the Formosan Medical Association
    • The impact of bisphosphonates on mortality and cardiovascular risk among osteoporosis patients after cardiovascular disease [2021]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Bisphosphonates for treating osteoporosis [2018]
• United States
  • American Society for Bone and Mineral Research
    • Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research [2016]
    • Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research [2014]
    • Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research [2007]
  • Journal of Bone and Mineral Research
    • Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart [2020]
  • Medical Care
    • Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk [2020]
  • Osteoporosis International
    • Cost-effectiveness of Five Versus Ten Years of Alendronate Treatment Prior to Drug Holiday for Women with Osteoporosis [2020]
• {Related topics}
  • Guidelines
    • Osteoporosis: prevention, treatment

Osteoporosis: calcium, nutrition

• Australia, New Zealand
  • Medical Journal of Australia
    • Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia [2009]
• Belgium
  • Belgian Bone Club
    • Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases [2015]
• Europe
  • European Menopause and Andropause Society
    • Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide [2018]
• India
  • Frontiers in Endocrinology
    • Modern India and the Tale of Twin Nutrient Deficiency–Calcium and Vitamin D–Nutrition Trend Data 50 Years-Retrospect, Introspect, and Prospect [2019]
• International
  • European Journal of Endocrinology
    • ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis [2020]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • The role of calcium supplementation in healthy musculoskeletal ageing: An Experts consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF) [2017]
  • International Osteoporosis Foundation
    • Global dietary calcium intake among adults: a systematic review [2017]
  • Nutrients
    • Assessment of the Methods Used to Develop Vitamin D and Calcium Recommendations—A Systematic Review of Bone Health Guidelines [2021]
  • Osteoporosis International
    • Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) [2012]
• Republic of Korea
  • Journal of Bone Metabolism
    • Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research [2015]
  • Nutrients
    • Association of Dietary Total Antioxidant Capacity with Bone Mass and Osteoporosis Risk in Korean Women: Analysis of the Korea National Health and Nutrition Examination Survey 2008–2011 [2021]
• United States
  • Agency for Healthcare Research and Quality
    • Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: An Evidence Review for the U.S. Preventive Services Task Force [2018]
  • Bone Health & Osteoporosis Foundation
    • Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation [2018]
    • Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology [2016]
    • Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation [2015]
  • Journal of Nutrition
    • Low Calcium Intake Among African Americans: Effects on Bones and Body Weight [2006]
  • PLoS ONE
    • Inadequate calcium and vitamin D intake and osteoporosis risk in older Americans living in poverty with food insecurities [2020]
  • U.S. Preventive Services Task Force
    • Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication [2018]
• {Related topics}
  • Guidelines
    • Osteoporosis: prevention, treatment

Osteoporosis: digestive system diseases

• Canada
  • Canadian Association of Gastroenterology
    • Canadian Association of Gastroenterology position statement: Hip fracture and proton pump inhibitor therapy – a 2013 update [2013]
  • Canadian Family Physician
    • Management of bone health in patients with celiac disease [2018]
    • Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures [2013]
• International
  • Canadian Journal of Gastroenterology
    • Evaluation and management of skeletal health in celiac disease: Position statement [2012]
  • Nutrition Journal
    • Prevalence of osteoporosis and osteopenia in men and premenopausal women with celiac disease: a systematic review [2019]
  • World Journal of Gastroenterology
    • Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease [2020]
• Republic of Korea
  • International Journal of Environmental Research and Public Health
    • Association between Peptic Ulcer Disease and Osteoporosis: The Population-Based Longitudinal Cohort Study in Korea [2019]
• Saudi Arabia
  • Saudi Medical Journal
    • Celiac disease-related osteopathy among Saudi celiac patients: Are we adherent to recommendations? [2017]
• Switzerland
  • Medicine
    • Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study [2017]
• United States
  • Archives of Osteoporosis
    • Osteoporosis in Colorectal Cancer Survivors: Analysis of the Linkage between SWOG Trial Enrollees and Medicare Claims [2019]
  • Scientific World Journal
    • Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines [2012]
• {Related topics}
  • Guidelines
    • Osteoporosis

Osteoporosis: epidemiology

• Asia
  • Osteoporosis and Sarcopenia
    • An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies study [2018]
• Australia
  • Australian Institute of Health and Welfare
    • Bone and joint health [2020]
• Brazil
  • Clinical Interventions in Aging
    • The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil [2015]
• Canada
  • Archives of Osteoporosis
    • An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA) [2022]
  • Osteoporosis International
    • The burden of illness of osteoporosis in Canada [2012]
• Chile
  • Journal of Osteoporosis
    • Epidemiology and Direct Medical Cost of Osteoporotic Hip Fracture in Chile [2020]
• China
  • BMC Public Health
    • Prevalence of osteoporosis in China: a meta-analysis and systematic review [2016]
  • Clinical Interventions in Aging
    • Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives [2015]
  • Frontiers in Public Health
    • The prevalence of osteoporosis in China, a community based cohort study of osteoporosis [2023]
  • JAMA Network Open
    • Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study [2021]
  • Journal of Bone and Mineral Research
    • Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study [2021]
    • The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey [2019]
• Europe
  • International Osteoporosis Foundation
    • Osteoporosis in the European Union: medical management, epidemiology and economic burden [2013]
    • Osteoporosis in the European Union: a compendium of country-specific reports [2013]
• Germany
  • BMC Musculoskeletal Disorders
    • Prevalence and comorbidity of osteoporosis– a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany [2018]
  • Deutsches Ärzteblatt International
    • The Epidemiology of Osteoporosis [2013]
• Hong Kong
  • Osteoporosis and Sarcopenia
    • Prevalence of osteoporosis in elderly women in Hong Kong [2021]
• India
  • International Osteoporosis Foundation
    • The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation [2014]
  • Journal of Mid-Life Health
    • Burden of Osteopenia and Osteoporosis Among Postmenopausal Women in India: A Systematic Review and Meta-Analysis [2022]
• International
  • British Medical Bulletin
    • The Epidemiology of Osteoporosis [2020]
  • International Osteoporosis Foundation
    • A systematic review of hip fracture incidence and probability of fracture worldwide [2012]
    • Secular trends in the incidence of hip and other osteoporotic fractures [2011]
    • Facts and Statistics
  • Journal of Orthopaedic Surgery and Research
    • The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis [2021]
    • Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis [2021]
• Iran
  • Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders
    • Prevalence of Osteoporosis Among Iranian Postmenopausal Women: A Systematic Review and Meta-analysis [2022]
  • International Journal of Preventive Medicine
    • Prevalence of Osteoporosis and Osteopenia in People Over 60 Years in Iran: A Systematic Review and Meta-analysis [2022]
  • Journal of Research in Medical Sciences
    • Prevalence of osteoporosis in Iran: A meta-analysis [2013]
• Italy
  • BMC Musculoskeletal Disorders
    • Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign [2016]
  • Bone
    • Trends in hip and distal femoral fracture rates in Italy from 2007 to 2017 [2021]
• Jordan
  • International Journal of Environmental Research and Public Health
    • Osteoporosis among Postmenopausal Women in Jordan: A National Cross-Sectional Study [2022]
• Latin America
  • Salud Pública de México
    • Epidemiology of osteoporosis in Latin America 2008 [2009]
• Middle East, North Africa
  • International Journal of Clinical Rheumatology
    • Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa [2018]
• Netherlands
  • Calcified Tissue International
    • Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements [2016]
  • PLoS Medicine
    • The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm [2015]
• Norway
  • BMC Geriatrics
    • Cause-specific excess mortality after hip fracture: the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) [2023]
• Republic of Korea
  • Endocrinology and Metabolism
    • Epidemiology of Osteoporosis and Osteoporotic Fractures in South Korea [2013]
  • Healthcare
    • Characteristics of Osteoporosis & Osteoporotic Fractures in Korea Based on Health Insurance Review and Assessment (HIRA) Database: 2009–2017 [2021]
  • International Journal of Environmental Research and Public Health
    • Influence of Residence Area and Basic Livelihood Conditions on the Prevalence and Diagnosis Experience of Osteoporosis in Postmenopausal Women Aged over 50 Years: Evaluation Using Korea National Health and Nutrition Examination Survey Data [2021]
  • Journal of Korean Medical Science
    • Trend in Hip Fracture Incidence and Mortality in Korea: A Prospective Cohort Study from 2002 to 2011 [2015]
    • New Reference Data on Bone Mineral Density and the Prevalence of Osteoporosis in Korean Adults Aged 50 Years or Older: The Korea National Health and Nutrition Examination Survey 2008-2010 [2014]
  • Osteoporosis International
    • Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey [2021]
  • PLoS ONE
    • Prevalence and diagnosis experience of osteoporosis in postmenopausal women over 50: Focusing on socioeconomic factors [2021]
  • Yonsei Medical Journal
    • Prevalence of Osteoporosis in the Korean Population Based on Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2011 [2014]
• Singapore
  • International Journal of Environmental Research and Public Health
    • Estimation of Prevalence of Osteoporosis Using OSTA and Its Correlation with Sociodemographic Factors, Disability and Comorbidities [2019]
• South-East Asia
  • Clinical Biochemist Reviews
    • Osteoporosis in South-East Asian Countries [2020]
• Sub-Saharan Africa
  • Ghana Medical Journal
    • A call to action for osteoporosis research in sub-saharan Africa [2020]
• United Kingdom
  • Bone
    • Epidemiology of Fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status [2016]
• United States
  • American Journal of Clinical Nutrition
    • African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox [2008]
  • Centers for Disease Control and Prevention
    • Osteoporosis
  • Journal of Bone and Mineral Research
    • The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine [2014]
  • Journal of Community Hospital Internal Medicine Perspectives
    • The trend of osteoporosis and osteoporotic fragility fractures in inpatients: results from a national database [2019]
• {Related topics}
  • Guidelines
    • Osteoporosis

Osteoporosis: genetics

• China
  • PLoS ONE
    • Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis [2017]
• International
  • Journal of Rheumatology
    • Metaanalysis Reveals Genetic Correlates of Osteoporosis Pathogenesis [2021]
  • Medicine
    • The association of OPG polymorphisms with risk of osteoporotic fractures [2021]
  • Nature Reviews Endocrinology
    • A road map for understanding molecular and genetic determinants of osteoporosis [2020]
• Japan
  • Bone Reports
    • Genetic risk score based on the prevalence of vertebral fracture in Japanese women with osteoporosis [2016]
• Republic of Korea
  • Genes
    • MYLK and PTGS1 Genetic Variations Associated with Osteoporosis and Benign Breast Tumors in Korean Women [2021]
• Romania
  • PLoS ONE
    • Polymorphisms of FDPS, LRP5, SOST and VKORC1 genes and their relation with osteoporosis in postmenopausal Romanian women [2019]
• Saudi Arabia
  • Genes
    • Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis [2021]
• United Kingdom
  • Royal Osteoporosis Society
    • Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis and Bone Research Academy of the Royal Osteoporosis Society on October 5th 2020 [2021]
• {Related topics}
  • Guidelines
    • Osteoporosis: risk factors

Osteoporosis: hormone replacement therapy

• Europe
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? [2020]
• {Related topics}
  • Guidelines
    • Osteoporosis: prevention, treatment

Osteoporosis: kidney diseases

• Egypt
  • Kidney Diseases
    • Consensus Evidence-Based Clinical Practice Recommendations for the Diagnosis and Treat-To-Target Management of Osteoporosis in Chronic Kidney Disease Stages G4-G5D and Post-transplantation: An Initiative of Egyptian Academy of Bone Health [2022]
• Europe
  • Nephrology Dialysis Transplantation
    • European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D [2021]
• France
  • Kidney International Reports
    • Longitudinal Bone Loss Occurs at the Radius in CKD [2021]
• International
  • Endocrine
    • A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease [2021]
  • Frontiers in Pharmacology
    • Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis [2022]
  • International Journal of Molecular Sciences
    • Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review [2020]
  • KDIGO
    • CKD-Mineral and Bone Disorder (CKD-MBD) [2017]
• Japan
  • Internal Medicine
    • Management of Osteoporosis in Chronic Kidney Disease [2017]
• Spain
  • Sociedad Española de Nefrologia
    • Spanish Society of Nephrology recommendations for controlling mineral and bone disorders in chronic kidney disease patients (S.E.N.-M.B.D.) [2011]
• United States
  • Clinical Journal of the American Society of Nephrology
    • Management of Osteoporosis in CKD [2018]
  • Cureus
    • Osteoporosis, an Inevitable Circumstance of Chronic Kidney Disease: A Systematic Review [2021]
• {Related topics}
  • Guidelines
    • Osteoporosis

Osteoporosis: parathyroid hormone

• Canada
  • Osteoporosis Canada
    • Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis [2006]
• Europe
  • Calcified Tissue International
    • Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS) [2018]
• International
  • Bone Reports
    • The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: A systematic review and meta-analysis [2020]
  • Therapeutic Advances in Musculoskeletal Disease
    • Update on the safety and efficacy of teriparatide in the treatment of osteoporosis [2019]
• Iran
  • Iranian Journal of Pharmaceutical Research
    • Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis [2019]
• Japan
  • Clinical Interventions in Aging
    • Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report [2016]
  • Osteoporosis and Sarcopenia
    • Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk [2019]
• Middle East
  • Journal of International Medical Research
    • Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide [2020]
• United States
  • Cureus
    • Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis [2017]
  • Current Osteoporosis Reports
    • Parathyroid Hormone and Parathyroid Hormone-related Protein Analogs as Therapies for Osteoporosis [2013]
• {Related topics}
  • Guidelines
    • Osteoporosis: prevention, treatment

Osteoporosis: prevention, treatment

• Asia-Pacific
  • Journal of the Formosan Medical Association
    • Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures [2023]
• Australia
  • Australian Family Physician
    • Medication selection and patient compliance in the clinical management of osteoporosis [2016]
    • Osteoporosis – prevention and detection in general practice [2012]
    • Osteoporosis – pharmacological prevention and management in older people [2012]
  • Australian Prescriber
    • Treating osteoporosis: risks and management [2022]
    • Treating osteoporosis [2016]
  • BMC Family Practice
    • Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice [2020]
  • BMC Research Notes
    • Knowledge change regarding osteoporosis prevention: translating recommended guidelines into user-friendly messages within a community forum [2015]
  • Cost Effectiveness and Resource Allocation
    • What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia [2016]
  • Medical Journal of Australia
    • Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention [2010]
• Austria, Germany, Switzerland
  • Osteoporosis International
    • Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators [2023]
• Baltic countries
  • Medicina
    • Use of drugs against osteoporosis in the Baltic countries during 2010–2014 [2016]
• Belgium
  • Belgian Bone Club
    • Extraskeletal benefits and risks of calcium, Vitamin D and anti-osteoporosis medications [2012]
    • Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club [2011]
    • Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club [2010]
• Brazil
  • Archives of Endocrinology and Metabolism
    • Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO) [2022]
• Bulgaria
  • Rheumatology and Therapy
    • Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria [2021]
• Canada
  • BMC Geriatrics
    • Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada [2015]
  • Canadian Academy of Sport and Exercise Medicine
    • Canadian Academy of Sport and Exercise Medicine Position Statement: Osteoporosis and Exercise [2013]
  • Canadian Agency for Drugs and Technologies in Health
    • Denosumab versus Zoledronic Acid for Adults with Osteoporosis: A Review of Cost-Effectiveness [2016]
    • Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms [2013]
  • Journal of the Canadian Dental Association
    • Building Osteoporosis Prevention into Dental Practice [2012]
  • MDM Policy & Practice
    • Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada [2019]
  • Osteoporosis Canada
    • Recommendations for preventing fracture in long-term care [2015]
• Canada, United States
  • Osteoporosis International
    • Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review [2022]
• China
  • Bioengineered
    • Chinese patent medicine for osteoporosis: a systematic review and meta-analysis [2022]
• Czech Republic
  • Acta Poloniae Pharmaceutica. Drug Research
    • Consumption of osteoanabolic drugs and strontium ranelate in the treatment of osteoporosis in the Czech Republic in 2005-2011 [2014]
• Denmark
  • International Journal of Circumpolar Health
    • The prevalence of patients treated for osteoporosis in Greenland is low compared to Denmark [2022]
  • Journal of Bone and Mineral Research
    • Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data [2015]
• Europe
  • Archives of Osteoporosis
    • Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium [2017]
  • European Alliance of Associations for Rheumatology
    • EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures [2017]
  • European Menopause and Andropause Society
    • EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture [2014]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review [2020]
    • Cutaneous Side Effects of Antiosteoporosis Treatments [2011]
  • European Union Geriatric Medicine Society
    • A Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement [2016]
  • Osteoporosis International
    • The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study [2021]
    • Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study [2015]
• France
  • PLoS ONE
    • Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study [2015]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Bone-Targeted Therapy [2015]
  • Institute for Quality and Efficiency in Health Care
    • Bisphosphonates, teriparatide and deno-sumab for the treatment of postmenopausal osteoporosis [2023]
• International
  • BMJ
    • Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials [2023]
  • European Journal of Physical and Rehabilitation Medicine
    • Osteoporosis guidelines from a rehabilitation perspective: systematic analysis and quality appraisal using AGREE II [2021]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs [2020]
    • Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) [2019]
  • Integrative Medicine Research
    • What traditional, complementary, and integrative medicine recommendations exist across osteoporosis clinical practice guidelines? A systematic review and quality assessment [2022]
  • International Journal of Behavioral Nutrition and Physical Activity
    • Evidence on physical activity and osteoporosis prevention for people aged 65+ years: a systematic review to inform the WHO guidelines on physical activity and sedentary behaviour [2020]
  • International Journal of Environmental Research and Public Health
    • Effects of Multicomponent Exercise Training on the Health of Older Women with Osteoporosis: A Systematic Review and Meta-Analysis [2022]
  • International Osteoporosis Foundation
    • The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors [2022]
    • How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey [2021]
    • Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle [2013]
  • Journal of Education and Health Promotion
    • Prevention of osteoporosis in menopausal women: A systematic review of nonpharmacological clinical trials [2022]
  • Journal of Frailty & Aging
    • Osteoporosis in Frail Older Adults: Recommendations for Research from the ICFSR Task Force 2020 [2021]
  • Medicine
    • Quality assessment of traditional and conventional medicine clinical practice guidelines for osteoporosis [2021]
  • Osteoporosis and Sarcopenia
    • Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines [2019]
  • Osteoporosis International
    • Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures [2017]
  • PharmacoEconomics
    • An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis [2021]
  • Scientific Reports
    • Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis [2020]
• Iran
  • Medical Journal of the Islamic Republic of Iran
    • Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran [2017]
• Ireland
  • Age and Ageing
    • Factors associated with initiation of bone-health medication among older adults in primary care in Ireland [2021]
  • Archives of Osteoporosis
    • Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland [2021]
• Italy
  • Journal of Orthopaedics and Traumatology
    • Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology [2017]
• Japan
  • Archives of Osteoporosis
    • Japanese 2011 guidelines for prevention and treatment of osteoporosis - executive summary [2012]
  • Clinical Interventions in Aging
    • Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia) [2014]
  • Journal of Epidemiology
    • Effect of Distributing an Evidence-Based Guideline for Prevention of Osteoporosis on Health Education Programs in Municipal Health Centers: A Randomized Controlled Trial [2012]
• Malta
  • Surgery Journal
    • Hip Fractures in Malta: Are we Missing an Opportunity? [2021]
• Netherlands, Sweden
  • Archives of Osteoporosis
    • Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control [2017]
• Republic of Korea
  • BMC Musculoskeletal Disorders
    • Association between the awareness of osteoporosis and the quality of care for bone health among Korean women with osteoporosis [2014]
  • Journal of Bone Metabolism
    • The Trend in the Sales of Menopausal Hormone and Other Osteoporosis Medications in South Korea from 2016 to 2019 [2021]
    • Position Statement: Exercise Guidelines to Increase Peak Bone Mass in Adolescents [2019]
    • Cost-effectiveness of Pharmaceutical Interventions to Prevent Osteoporotic Fractures in Postmenopausal Women with Osteopenia [2016]
    • National Healthcare Budget Impact Analysis of the Treatment for Osteoporosis and Fractures in Korea [2013]
  • Journal of Korean Medical Science
    • Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea [2021]
  • Osteoporosis and Sarcopenia
    • The secular trends in the use of medications for osteoporosis in South Korea using Intercontinental Medical Statistics Health Sales Audit 2006–2018 [2020]
  • PLoS ONE
    • Comparison of the Prescribing Pattern of Bisphosphonate and Raloxifene in Korean Women with Osteoporosis: From a National Health Insurance Claims Database [2015]
• Republic of Korea, Spain, United States
  • American Journal of Medicine
    • Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study [2015]
• Spain
  • ClinicoEconomics and Outcomes Research
    • Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain [2013]
  • Drugs in R&D
    • Identifying and managing patients at high risk for fractures: conclusions from the second Spanish multidisciplinary forum-parathyroid hormone use in osteoporotic patients at high risk for fractures [2012]
  • PLoS ONE
    • Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain [2015]
• Spain, United Kingdom
  • Clinical Epidemiology
    • Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database [2018]
• Switzerland
  • European Spine Journal
    • Recommendations for raloxifene use in daily clinical practice in the Swiss setting [2012]
  • Swiss Medical Weekly
    • 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) [2020]
• Taiwan
  • BMC Geriatrics
    • Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study [2019]
  • Journal of the Formosan Medical Association
    • Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update [2023]
• Turkey
  • Osteoporosis International
    • No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study [2021]
• United Kingdom
  • Bone
    • Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity [2017]
  • British Menopause Society
    • Prevention and treatment of osteoporosis in women [2023]
  • Journal of Orthopaedic Surgery and Research
    • Secondary prevention of osteoporosis in non-neck of femur fragility fractures: is it value for money? A retrospective, prospective and cross-sectional cohort study [2013]
  • National Institute for Health and Care Excellence
    • Romosozumab for treating severe osteoporosis [2022]
    • Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women [2018]
    • Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women [2018]
    • Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women [2017]
    • Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women [2017]
    • Denosumab for the prevention of osteoporotic fractures in postmenopausal women [2010]
  • National Osteoporosis Guideline Group
    • UK clinical guideline for the prevention and treatment of osteoporosis [2022]
  • Office for Health Improvement and Disparities
    • Musculoskeletal health: applying All Our Health
    • Falls and fractures: applying All Our Health
  • Osteoporosis International
    • Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study [2017]
    • Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010 [2015]
  • Royal Osteoporosis Society
    • Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance [2022]
    • Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis [2022]
    • Effective secondary prevention of fragility fractures: Clinical standards for Fracture Liaison Services [2019]
• United States
  • Agency for Healthcare Research and Quality
    • Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review [2019]
    • Changes in Osteoporosis Medication Use and Expenditures among Women (Age >= 50), United States, 2000 to 2011 [2014]
    • Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report [2012]
  • American Academy of Pediatrics
    • Optimizing Bone Health in Children and Adolescents [2014]
  • American College of Physicians
    • Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians [2023]
    • Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians [2023]
    • Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women [2017]
  • American Physical Therapy Association
    • Physical Therapist Management of Patients With Suspected or Confirmed Osteoporosis: A Clinical Practice Guideline From the Academy of Geriatric Physical Therapy [2022]
  • American Society for Bone and Mineral Research
    • Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition [2020]
    • Osteoporosis therapeutics: recent developments at ASBMR [2016]
    • Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention [2012]
  • Annals of Pharmacotherapy
    • Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States [2019]
  • Bone Health & Osteoporosis Foundation
    • The clinician's guide to prevention and treatment of osteoporosis [2022]
    • Clinician’s Guide to Prevention and Treatment of Osteoporosis [2014]
  • Endocrine Society
    • Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update [2020]
    • Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline [2019]
  • Journal of Bone and Mineral Research
    • Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011 [2014]
  • Journal of Rheumatology
    • Patient Perceptions of Osteoporosis Treatment Thresholds [2014]
  • Pharmacy and Therapeutics
    • Osteoporosis: A Review of Treatment Options [2018]
  • Seminars in Arthritis and Rheumatism
    • Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective [2020]
• {Related topics}
  • Guidelines
    • Osteoporosis: vitamin D
    • Osteoporosis: parathyroid hormone
    • Osteoporosis: hormone replacement therapy
    • Osteoporosis: calcium, nutrition
    • Osteoporosis: bisphosphonates
    • Osteoporosis

Osteoporosis: risk factors

• Asia-Pacific
  • International Osteoporosis Foundation
    • Consensus of Official Position of IOF/ISCD FRAX Initiatives in Asia-Pacific Region [2014]
• Australia
  • Australian Journal of General Practice
    • Personalised assessment of fracture risk: Which tool to use? [2022]
    • Fracture risk prediction and the decision to treat low bone density [2021]
  • Journal of Clinical Medicine
    • Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants [2022]
• Austria
  • Archives of Osteoporosis
    • Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk [2022]
• Belgium
  • Belgian Bone Club
    • Skeletal health in breast cancer survivors [2017]
• Canada
  • BMC Musculoskeletal Disorders
    • The osteoporosis care gap in Canada [2004]
  • Canadian Paediatric Society
    • Evaluating and optimizing bone health in children with chronic health conditions [2022]
• China
  • Evidence-based Complementary and Alternative Medicine
    • Diabetic Osteoporosis: A Review of Its Traditional Chinese Medicinal Use and Clinical and Preclinical Research [2016]
  • Iranian Journal of Public Health
    • Prevalence of Osteoporosis in Patients with Type 2 Diabetes Mellitus in the Chinese Mainland: A Systematic Review and Meta-Analysis [2019]
• Europe
  • Archives of Osteoporosis
    • Prevalence of FRAX risk factors and the osteoporosis treatment gap among women >= 70 years of age in routine primary care across 8 countries in Europe [2022]
  • European Menopause and Andropause Society
    • Osteoporosis management in patients with breast cancer: EMAS position statement [2017]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting [2017]
  • European Society for Medical Oncology
    • Bone health in cancer: ESMO Clinical Practice Guidelines [2020]
  • European Society of Endocrinology
    • European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders [2022]
  • International Journal of Environmental Research and Public Health
    • Environmental Substances Associated with Osteoporosis–A Scoping Review [2021]
  • International Journal of Hygiene and Environmental Health
    • Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and Belgium [2021]
• Germany
  • Archives of Gynecology and Obstetrics
    • Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data [2021]
  • Breast Care
    • Breast Cancer and Osteoporosis – Management of Cancer Treatment-Induced Bone Loss in Postmenopausal Women with Breast Cancer [2014]
  • Rheumatology International
    • Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017 [2020]
• India
  • Lung India
    • Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India [2014]
• International
  • BMC Endocrine Disorders
    • Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies [2023]
  • Bone
    • Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®) [2021]
  • Calcified Tissue International
    • Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women; a meta-analysis of international cohorts [2014]
  • Clinical Infectious Diseases
    • Recommendations for Evaluation and Management of Bone Disease in HIV [2015]
  • International Journal of Environmental Research and Public Health
    • Association between Environmental Cadmium Exposure and Osteoporosis Risk in Postmenopausal Women: A Systematic Review and Meta-Analysis [2023]
  • International Osteoporosis Foundation
    • The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis [2023]
    • Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden? [2022]
    • Osteoporosis management in hematologic stem cell transplant recipients: Executive summary [2021]
    • FRAX and ethnicity [2021]
    • Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors [2019]
    • Diagnosis and management of bone fragility in diabetes: an emerging challenge [2018]
  • Journal of Bone Oncology
    • Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer [2021]
    • Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations [2021]
  • Journal of Clinical Endocrinology & Metabolism
    • Bone Health in Adults With Prader–Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study [2023]
  • Journal of Eating Disorders
    • Associations between bone mineral density, body composition and amenorrhoea in females with eating disorders: a systematic review and meta-analysis [2022]
  • Osteoporosis International
    • Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures [2019]
    • Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus [2017]
  • PLoS ONE
    • Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors [2020]
    • Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence [2016]
  • Scientific Reports
    • The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis [2022]
  • University of Sheffield
    • FRAX®
• Kuwait
  • Osteoporosis International
    • FRAX- vs. T-score-based intervention thresholds for osteoporosis [2017]
• Kyrgyzstan
  • Archives of Osteoporosis
    • A surrogate FRAX model for the Kyrgyz Republic [2020]
• Netherlands
  • Drugs & Aging
    • Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide [2019]
  • Osteoporosis International
    • Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands [2011]
  • Respiratory Research
    • Fracture prevention in COPD patients; a clinical 5-step approach [2015]
• New Zealand
  • Starship
    • Bone health and calcium metabolism in paediatric oncology [2020]
• Pakistan
  • Archives of Osteoporosis
    • A surrogate FRAX model for Pakistan [2021]
• Republic of Korea
  • Archives of Osteoporosis
    • Association between blood cadmium levels and the risk of osteopenia and osteoporosis in Korean post-menopausal women [2021]
  • BMC Public Health
    • Incidence of osteoporosis and ambient air pollution in South Korea: a population-based retrospective cohort study [2021]
  • BMC Women's Health
    • Association between body mass index and fragility fracture in postmenopausal women: a cross-sectional study using Korean National Health and Nutrition Examination Survey 2008–2009 (KNHANES IV) [2021]
  • International Journal of Environmental Research and Public Health
    • Association between Osteoporosis and Low Hemoglobin Levels: A Nested Case–Control Study Using a National Health Screening Cohort [2021]
  • JAMA Network Open
    • Association of Female Reproductive Factors With Incidence of Fracture Among Postmenopausal Women in Korea [2021]
  • Journal of Korean Medical Science
    • The Epidemiology of Fracture in Patients with Acute Ischemic Stroke in Korea [2019]
  • Journal of Preventive Medicine and Public Health
    • Association Between Parity and Low Bone Density Among Postmenopausal Korean Women [2021]
  • PLoS ONE
    • Development of a Korean Fracture Risk Score (KFRS) for Predicting Osteoporotic Fracture Risk: Analysis of Data from the Korean National Health Insurance Service [2016]
    • Age at First Delivery and Osteoporosis Risk in Korean Postmenopausal Women: The 2008–2011 Korea National Health and Nutrition Examination Survey (KNHANES) [2015]
  • Scientific Reports
    • Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study [2021]
  • Viruses
    • Human Papillomavirus Infections and Increased Risk of Incident Osteoporosis: A Nationwide Population-Based Cohort Study [2023]
• Singapore
  • Archives of Osteoporosis
    • Use of age-dependent FRAX-based intervention thresholds for Singapore [2020]
• Sweden
  • Osteoporosis International
    • Eating disorders are associated with increased risk of fall injury and fracture in Swedish men and women [2022]
• Taiwan
  • International Journal of Chronic Obstructive Pulmonary Disease
    • Prescription Patterns in Patients with Chronic Obstructive Pulmonary Disease and Osteoporosis [2021]
  • Medicine
    • Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis [2022]
  • Nutrients
    • Iron Deficiency Anemia as a Risk Factor for Osteoporosis in Taiwan: A Nationwide Population-Based Study [2017]
  • PLoS ONE
    • Association between type 2 diabetes and osteoporosis risk: A representative cohort study in Taiwan [2021]
    • Development and Validation of an Osteoporosis Self-Assessment Tool for Taiwan (OSTAi) Postmenopausal Women-A Sub-Study of the Taiwan OsteoPorosis Survey (TOPS) [2015]
  • Scientific Reports
    • Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan [2021]
• Thailand
  • Archives of Osteoporosis
    • Temporal changes in access to FRAX® in Thailand between 2010 and 2018 [2019]
• Turkey
  • Journal of Bone Metabolism
    • Agreement between the Turkey Guidelines and the Fracture Risk Assessment Tool®-based Intervention Threshold [2018]
• Ukraine
  • Journal of Osteoporosis
    • FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine [2021]
• United Kingdom
  • Age and Ageing
    • Assessment and management of fracture risk in patients with Parkinson's disease [2015]
  • BMJ
    • Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores [2011]
  • BMJ Open
    • Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study [2019]
  • BMJ Quality Improvement Reports
    • Are patients with newly diagnosed breast cancer getting appropriate DEXA scans? A District General Hospital experience [2015]
  • International Journal of Chronic Obstructive Pulmonary Disease
    • Management of Fracture Risk in Patients with Chronic Obstructive Pulmonary Disease (COPD): Building a UK Consensus Through Healthcare Professional and Patient Engagement [2020]
  • National Osteoporosis Guideline Group
    • A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation [2016]
  • Osteoporosis International
    • Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: An analysis of the UK SCOOP Trial [2020]
• United States
  • American Society of Clinical Oncology
    • Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline [2019]
  • Archives of Osteoporosis
    • Predictors of imminent risk of fracture in Medicare-enrolled men and women [2020]
  • Bone Health & Osteoporosis Foundation
    • The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations [2016]
  • Clinical Infectious Diseases
    • Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers [2010]
  • Journal of Stroke and Cerebrovascular Diseases
    • Association between post-stroke disability and 5-year hip-fracture risk: The Women’s Health Initiative [2020]
  • Open Forum Infectious Diseases
    • Bone Mineral Density Screening Among People With HIV: A Population-Based Analysis in the United States [2021]
  • Scientific Reports
    • Trends in osteoporosis and mean bone density among type 2 diabetes patients in the US from 2005 to 2014 [2021]
• {Related topics}
  • Guidelines
    • Osteoporosis: genetics
    • Osteoporosis

Osteoporosis: screening, diagnosis

• Asia, Europe
  • Osteoporosis International
    • Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review [2021]
• Australia
  • Australian Family Physician
    • Bone turnover markers [2013]
  • Australian Prescriber
    • Diagnostic tests: Bone mineral density: testing for osteoporosis [2016]
• Canada
  • Canadian Association of Radiologists
    • Canadian Association of Radiologists Technical Standards for Bone Mineral Densitometry Reporting [2013]
  • Canadian Family Physician
    • Screening for primary prevention of fragility fractures [2023]
  • Canadian Task Force on Preventive Health Care
    • Fragility Fractures (2023) [2023]
  • CMAJ Open
    • Impact of a change in physician reimbursement on bone mineral density testing in Ontario, Canada: a population-based study [2014]
  • Journal of Clinical Densitometry
    • Evaluation of Automated Fracture Risk Assessment Based on the Canadian Association of Radiologists and Osteoporosis Canada Assessment Tool [2016]
  • Osteoporosis International
    • Quality of fracture risk assessment in post-fracture care in Ontario, Canada [2012]
• China
  • Quantitative Imaging in Medicine and Surgery
    • Fine-tuning the cutpoint T-score as an epidemiological index with high specificity for osteoporosis: methodological considerations for the Chinese population [2022]
    • Estimations of bone mineral density defined osteoporosis prevalence and cutpoint T-score for defining osteoporosis among older Chinese population: a framework based on relative fragility fracture risks [2022]
    • Chinese expert consensus on the diagnosis of osteoporosis by imaging and bone mineral density [2020]
• Europe
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) [2019]
    • Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice [2015]
• International
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis [2019]
  • Insights into Imaging
    • A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative [2017]
  • International Osteoporosis Foundation
    • Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group [2022]
    • Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services [2021]
    • Recommendations for bone marker standards in osteoporosis: what, why and where to now? [2011]
    • Validation of the IOF quality of life questionnaire for patients with wrist fracture [2009]
  • International Society for Clinical Densitometry
    • Bone densitometry worldwide: a global survey by the ISCD and IOF [2020]
    • Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance [2016]
    • Official Positions
  • Osteoporosis International
    • Harmonization of commercial assays for PINP; the way forward [2020]
    • Guidelines for Assessment of Bone Density and Microarchitecture In Vivo Using High-Resolution Peripheral Quantitative Computed Tomography [2020]
  • PLoS ONE
    • Screening for osteoporosis: A systematic assessment of the quality and content of clinical practice guidelines, using the AGREE II instrument and the IOM Standards for Trustworthy Guidelines [2018]
• Ireland
  • BMJ Open
    • The Irish dual-energy X-ray absorptiometry (DXA) Health Informatics Prediction (HIP) for Osteoporosis Project [2020]
• Japan
  • Clinica Chimica Acta
    • Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition) [2019]
• Malaysia
  • Archives of Osteoporosis
    • Screening and management of osteoporosis: a survey of knowledge, attitude and practice among primary care physicians in Malaysia [2022]
  • Mædica
    • Screening and Diagnosing Osteoporosis Among Postmenopausal Women in Primary Care Settings in Malaysia: A Systematic Review [2022]
• Netherlands
  • Osteoporosis International
    • Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture [2017]
• Republic of Korea
  • Annals of Laboratory Medicine
    • Current Recommendations for Laboratory Testing and Use of Bone Turnover Markers in Management of Osteoporosis [2012]
  • Journal of Bone Metabolism
    • Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research [2015]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Osteoporosis: assessing the risk of fragility fracture [2017]
  • Royal College of Radiologists
    • Radiological guidance for the recognition and reporting of osteoporotic vertebral fragility fractures (VFFs) [2021]
  • Royal Osteoporosis Society
    • Reporting dual energy X-ray absorptiometry scans in adult fracture risk assessment: Standards for quality [2019]
  • UK National Screening Committee
    • Osteoporosis
• United States
  • Agency for Healthcare Research and Quality
    • Screening to Prevent Osteoporotic Fractures: An Evidence Review for the U.S. Preventive Services Task Force [2018]
  • American Academy of Pediatrics
    • Bone Densitometry in Children and Adolescents [2016]
  • American College of Radiology
    • Osteoporosis and Bone Mineral Density
    • ACR–SPR–SSR Practice Parameter for the Performance of Quantitative Computed Tomography (QCT) Bone Densitometry
    • ACR–SPR–SSR Practice Parameter for the Performance of Dual-Energy X-Ray Absorptiometry (DXA)
  • American Society for Bone and Mineral Research
    • Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee [2013]
  • Journal of Bone and Mineral Research
    • Osteoporosis Screening in Postmenopausal Women 50-64 years-old: Comparison of U.S. Preventive Services Task Force Strategy and Two Traditional Strategies in the Women's Health Initiative [2014]
  • Medical Care
    • Effect of Self-Referral on Bone Mineral Density Testing and Osteoporosis Treatment [2014]
  • Osteoporosis International
    • Real-world bone turnover marker use: impact on treatment decisions and fracture [2021]
  • U.S. Preventive Services Task Force
    • Osteoporosis to Prevent Fractures: Screening [2018]
• {Related topics}
  • Guidelines
    • Osteoporosis

Osteoporosis: vitamin D

• Australia
  • Australasian Journal on Ageing
    • Vitamin D, bones and muscle: myth versus reality [2017]
  • Australian Family Physician
    • Vitamin D and the musculoskeletal health of older adults [2012]
• Australia, New Zealand
  • Medical Journal of Australia
    • Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement [2006]
• Bangladesh
  • Asia Pacific Journal of Clinical Nutrition
    • Vitamin D deficiency in Bangladesh: A review of prevalence, causes and recommendations for mitigation [2022]
• Canada
  • BCGuidelines
    • Vitamin D Testing [2019]
  • Canadian Agency for Drugs and Technologies in Health
    • Vitamin D Testing in the General Population: A Review of the Clinical and Cost-Effectiveness and Guidelines [2015]
  • Canadian Family Physician
    • Reduce unnecessary routine vitamin D testing [2023]
  • Journal of Osteoporosis
    • Characterizing the Assessment and Management of Vitamin D Levels in Patients with Osteoporosis in Clinical Practice: A Chart Review Initiative [2015]
  • Osteoporosis Canada
    • Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada [2010]
• China
  • Clinical Interventions in Aging
    • Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review [2014]
• Europe
  • European Menopause and Andropause Society
    • EMAS position statement: Vitamin D and postmenopausal health [2012]
  • European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
    • Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group [2022]
• France
  • Osteoporosis International
    • Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France [2017]
• India
  • Nutrients
    • Vitamin D Deficiency in India: Prevalence, Causalities and Interventions [2014]
• International
  • Nutrients
    • Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review [2023]
  • Public Health Nutrition
    • 25-Hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis [2020]
• Italy
  • Nutrients
    • Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) [2022]
    • Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults [2018]
• Japan
  • Endocrine Journal
    • Assessment criteria for vitamin D deficiency/insufficiency in Japan — proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan [2016]
• Middle East, North Africa
  • Bone Reports
    • Vitamin D in the Middle East and North Africa [2018]
• New Zealand
  • Ministry of Health New Zealand
    • Consensus Statement on Vitamin D and Sun Exposure in New Zealand [2012]
• Republic of Korea
  • Journal of Bone Metabolism
    • Position Statement: Vitamin D Intake to Prevent Osteoporosis and Fracture in Adults [2022]
  • Yonsei Medical Journal
    • Association between Daily Sunlight Exposure and Fractures in Older Korean Adults with Osteoporosis: A Nationwide Population-Based Cross-Sectional Study [2021]
• Saudi Arabia
  • Archives of Osteoporosis
    • Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) [2016]
• Spain
  • Nutrients
    • Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency [2020]
• United Kingdom
  • National Institute for Health and Care Excellence
    • COVID-19 rapid guideline: vitamin D [2022]
    • Vitamin D: supplement use in specific population groups [2017]
  • Public Health England
    • Vitamin D supplementation during winter: PHE and NICE statement
  • Royal Osteoporosis Society
    • Vitamin D and bone health in adults [2020]
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force [2021]
  • Endocrine Connections
    • Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline [2013]
  • Endocrine Society
    • Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline [2011]
  • Society for Adolescent Health and Medicine
    • Recommended Vitamin D Intake and Management of Low Vitamin D Status in Adolescents: A Position Statement of the Society for Adolescent Health and Medicine [2013]
  • U.S. Preventive Services Task Force
    • Vitamin D Deficiency in Adults: Screening [2021]
• {Related topics}
  • Guidelines
    • Osteoporosis: prevention, treatment